in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Generic Drug User Fee Program Goes to Congress
3:00 PM MST | January 18, 2012 | Deepti Ramesh
The U.S. FDA says it has completed its recommendations for the proposed generic drug user fee program (GDUFA). The recommendations were transmitted by the Department of Health and Human Services to Congress on January 13. Under a user fee program, industry agrees to pay fees to help fund a portion of the FDA’s drug review activities while the FDA agrees to overall performance goals such as reviewing a certain percentage of applications within a particular time frame. The GDUFA is expected to create a level playing field for U.S. and overseas manufacturers...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee